Related Experiment Video
Updated: Jun 19, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia
Zhiqian Tong1, Jinling Zhang, Wenhong Luo
1State Key Lab of Brain and Cognitive Sciences, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Abstract:
It is widely known that exogenous formaldehyde exposure induces human cognitive impairment and animal memory loss; and recent studies show that formaldehyde at pathological levels induces Aβ deposition and misfolding of tau protein to form globular amyloid-like aggregates. Endogenous formaldehyde may be a marker for progressive senile dementia. The aim of this study was to investigate the correlation of endogenous formaldehyde in urine of senile dementia and mini mental state examination (MMSE) scores. Formaldehyde level was analyzed by high-performance liquid chromatography (with fluorescence detection) in human urine from dementia patients (n=141), patients with hypertension (n=33) or diabetes (n=16) and healthy individuals (n=38), autopsy hippocampus samples from Alzheimer's disease (AD) patients and brains of three types of AD animal model: namely, senescence accelerated mice (SAMP8), APP-transgenic mice and APP/PS1-transgenic mice. In a double-blind study, there was marked elevation of urine formaldehyde levels in patients (n=91) with dementia, and a slight increase in patients (n=50) with mild cognitive impairment. Urine formaldehyde level was inversely correlated with mini mental state examination scores (Rs=-0.441, p<0.0001). Furthermore, formaldehyde levels were significantly increased in the autopsy hippocampus from Alzheimer's patients (n=4). In SAMP8 brains the formaldehyde level was significantly increased, suggesting that the endogenous formaldehyde is related to aging in mice. The brain formaldehyde level in APP/PS1-transgenic (n=8) mice at age of 3 months and APP-transgenic (n=8) mice at age of 6 months was increased (0.56 ± 0.02 mM), respectively, as compared with their respective age-matched controls, when these two types of AD-like animals, respectively, started to form Aβ deposits and memory loss obviously. According to the level of formaldehyde in the brain of the transgenic mice, we treated normal mice with formaldehyde (0.5mM, intraperitoneal administration) and observed the memory loss of the animal in Morris water maze trial. Cognitive impairments for the senile dementia are probably related to endogenous formaldehyde levels; and the mini mental state examination scores referred to the evaluation of urine formaldehyde level in dementia patients may be used as a non-invasive method for the investigation and diagnosis of senile dementia.
Insights
Elevated endogenous formaldehyde in urine correlates with senile dementia and lower cognitive scores. This finding suggests urine formaldehyde may serve as a non-invasive biomarker for dementia diagnosis.
Area of Science:
- Neuroscience
- Biochemistry
- Gerontology
Background:
- Exogenous formaldehyde exposure is known to impair cognition and memory.
- Recent studies link pathological formaldehyde levels to amyloid-beta (Aβ) deposition and tau protein misfolding.
- Endogenous formaldehyde is proposed as a potential biomarker for progressive senile dementia.
Purpose of the Study:
- To investigate the correlation between endogenous formaldehyde levels in urine and cognitive function in senile dementia patients.
- To assess the relationship between urine formaldehyde levels and Mini-Mental State Examination (MMSE) scores.
- To explore the role of endogenous formaldehyde in Alzheimer's disease (AD) and aging-related cognitive decline.
Main Methods:
- High-performance liquid chromatography with fluorescence detection was used to analyze formaldehyde levels in human urine samples.
- Urine samples were collected from dementia patients, individuals with mild cognitive impairment, hypertension, diabetes, and healthy controls.
- Formaldehyde levels were also measured in autopsy hippocampus samples from AD patients and brains of AD animal models (SAMP8, APP-transgenic, APP/PS1-transgenic mice).
Main Results:
- Significantly elevated urine formaldehyde levels were observed in dementia patients and mildly elevated levels in those with mild cognitive impairment.
- Urine formaldehyde levels showed a significant inverse correlation with MMSE scores (Rs=-0.441, p<0.0001).
- Increased formaldehyde levels were found in the hippocampus of AD patients and in the brains of aging and AD-like transgenic mice, correlating with Aβ deposition and memory loss.
Conclusions:
- Cognitive impairments in senile dementia are likely associated with endogenous formaldehyde levels.
- Urine formaldehyde levels may serve as a non-invasive method for the investigation and diagnosis of senile dementia.
- Endogenous formaldehyde is implicated in aging-related cognitive decline and Alzheimer's disease pathogenesis.
Related Concept Videos
Urine Studies I: Urinalysis
Serum Studies: Renal Function Tests
Alzheimer Disease l: Introduction
Urodynamic Studies: Uroflowmetry
Dementia l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

